Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Morgan Stanley (MS-PQ) Gains from Sales and Divestitures (2016 - 2018)

Morgan Stanley (MS-PQ) has disclosed Gains from Sales and Divestitures for 9 consecutive years, with $27.0 million as the latest value for Q4 2018.

  • Quarterly Gains from Sales and Divestitures fell 20.59% to $27.0 million in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $27.0 million through Dec 2018, down 20.59% year-over-year, with the annual reading at $27.0 million for FY2018, 20.59% down from the prior year.
  • Gains from Sales and Divestitures for Q4 2018 was $27.0 million at Morgan Stanley, down from $34.0 million in the prior quarter.
  • The five-year high for Gains from Sales and Divestitures was $48.0 million in Q4 2014, with the low at $27.0 million in Q4 2018.
  • Average Gains from Sales and Divestitures over 5 years is $39.4 million, with a median of $40.0 million recorded in 2016.
  • The sharpest move saw Gains from Sales and Divestitures skyrocketed 33.33% in 2014, then decreased 20.59% in 2018.
  • Over 5 years, Gains from Sales and Divestitures stood at $48.0 million in 2014, then changed by 0.0% to $48.0 million in 2015, then dropped by 16.67% to $40.0 million in 2016, then dropped by 15.0% to $34.0 million in 2017, then dropped by 20.59% to $27.0 million in 2018.
  • According to Business Quant data, Gains from Sales and Divestitures over the past three periods came in at $27.0 million, $34.0 million, and $40.0 million for Q4 2018, Q4 2017, and Q4 2016 respectively.